Overview

The Optimal Treatment for Treatment-resistant Schizophrenia

Status:
Unknown status
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
The Optimal Treatment for Treatment-resistant Schizophrenia
Phase:
N/A
Details
Lead Sponsor:
Shanghai Mental Health Center
Treatments:
Aripiprazole
Clozapine
Risperidone
Valproic Acid